We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement
Analytical Cannabis Logo
×

Home > News > Psychedelics

Psychedelics Company to Provide Free LSD to Researchers

By Leo Bear-McGuinness

Published: Jun 09, 2022   

Complete the form below and we will email you a PDF version of "Psychedelics Company to Provide Free LSD to Researchers "

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Analytical Cannabis?

Analytical Cannabis Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Psychedelics Company to Provide Free LSD to Researchers

The psychedelics company Ceruvia Lifesciences is offering to supply LSD, at no cost, to qualified researchers.

According to the company, this particular batch of LSD on offer is the first to have met the stringent current good manufacturing practices (CGMP) standards required by the US Food and Drug Administration (FDA).

In an announcement on May 31, Ceruvia said that the provision of this LSD will be key to “advancing research into LSD’s safety and efficacy” for the treatment of conditions such as cluster headaches, alcohol use disorder, and anxiety disorder.

The company also intends to supply the first US-based trials of LSD in human subjects to take place for decades. These are scheduled to be conducted at NYU Langone's Center for Psychedelic Medicine and John Hopkins’ Center for Psychedelics and Consciousness Research, although neither trial is currently registered on the National Institute of Health’s database of clinical trials.

“Ceruvia Lifesciences is proud to have produced the world’s first CGMP LSD, which we will offer at no cost to help researchers looking to advance the development of LSD treatments for approved use in patients with unmet medical needs,” Carey Turnbull, founder and CEO of Ceruvia Lifesciences, said in a statement.

Any researchers interested in applying for some of Ceruvia’s LSD can do so by completing a form, which can be found here.

 

Like what you just read? You can find similar content on the topic tags shown below.

Science & Health Psychedelics

Stay connected with the latest news in cannabis extraction, science and testing

Get the latest news with the FREE weekly Analytical Cannabis newsletter

 
Advertisement